Comparison 3. Ethinylestradiol and cyproterone acetate versus ethinylestradiol and norgestrel.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Number of participants reporting non‐serious adverse effects | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Participant global assessment VAS (higher number indicates improvement) | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected |